
Dapgel7.5%
Ziska Pharmaceuticals Ltd.
Dapsone is a sulfone-class antibacterial and anti-inflammatory agent used for the following indications: Established / FDA-approved uses Leprosy (Hansen's disease): Dapsone is a core component of…
Dapsone is a sulfone-class antibacterial and anti-inflammatory agent used for the following indications:
Dapsone is not effective against sulfone-resistant strains of Mycobacterium leprae.
Dosage of Dapsone is individualized by indication. It should always be taken exactly as prescribed by a physician.
| Indication | Adult dose | Pediatric dose |
|---|---|---|
| Leprosy (WHO-MDT) | 100 mg once daily, combined with other antileprosy drugs, for the duration specified by the WHO MDT regimen (6 months for paucibacillary, 12 months for multibacillary disease) | Weight-based dose (approximately 1–2 mg/kg/day) per WHO pediatric MDT blister-pack regimens |
| Dermatitis herpetiformis | Initially 50 mg/day, titrated as needed within a 50–300 mg/day range to control skin lesions, then reduced to the lowest effective maintenance dose | Correspondingly smaller weight-based doses under specialist supervision |
| PCP prophylaxis (off-label) | Typically 100 mg once daily (regimens vary; may be combined with pyrimethamine/leucovorin) per treating physician's guidance | Weight-based dosing per pediatric infectious disease guidance |
| Acne vulgaris (topical gel) | Apply a thin layer to affected areas once daily (7.5% gel) or twice daily (5% gel) after cleansing | Approved for patients 12 years and older; same application instructions |
Dapsone tablets are usually taken orally, with or without food. See Precautions for required baseline and monitoring tests (G6PD status, complete blood count).
Adverse effects of Dapsone range from common and mild to rare but serious:
Patients should seek urgent medical attention for unusual paleness, fatigue, blue-tinged skin/lips, fever with rash, sore throat, or unusual bruising/bleeding while on Dapsone.
Dapsone is contraindicated in patients with known hypersensitivity to Dapsone or other sulfone compounds. There are no other well-established absolute contraindications; other risk factors (e.g., G6PD deficiency, hepatic impairment) require caution and monitoring rather than being absolute contraindications — see Precautions and Warnings.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.